カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の認知増強医薬品市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Cognition-Enhancing Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19239）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19239
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：94
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の認知増強医薬品市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

認知増強医薬品市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の認知増強医薬品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

認知増強医薬品市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・経口、注射

用途別セグメントは次のように区分されます。
・病院薬局、ドラッグストア、小売店

世界の認知増強医薬品市場の主要な市場プレーヤーは以下のとおりです。
・Accelerated Intelligence、Cognition Therapeutics、Cogstate、HVMN、Biogen Idec

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、認知増強医薬品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な認知増強医薬品メーカーの企業概要、2019年～2022年までの認知増強医薬品の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な認知増強医薬品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別認知増強医薬品の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの認知増強医薬品の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での認知増強医薬品市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および認知増強医薬品の産業チェーンを掲載しています。
・第13、14、15章では、認知増強医薬品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 認知増強医薬品の概要
- 種類別分析（2017年vs2021年vs2028年）：経口、注射
- 用途別分析（2017年vs2021年vs2028年）：病院薬局、ドラッグストア、小売店
- 世界の認知増強医薬品市場規模・予測
- 世界の認知増強医薬品生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Accelerated Intelligence、Cognition Therapeutics、Cogstate、HVMN、Biogen Idec
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：経口、注射
・用途別分析2017年-2028年：病院薬局、ドラッグストア、小売店
・認知増強医薬品の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・認知増強医薬品のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・認知増強医薬品のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・認知増強医薬品の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・認知増強医薬品の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Cognition-Enhancing Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Cognition-Enhancing Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Cognition-Enhancing Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Cognition-Enhancing Drugs include Accelerated Intelligence, Cognition Therapeutics, Cogstate, HVMN, and Biogen Idec, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cognition-Enhancing Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Injection
Market segment by Application can be divided into
Hospital Pharmacies
Drug Stores
Retail Pharmacies
The key market players for global Cognition-Enhancing Drugs market are listed below:
Accelerated Intelligence
Cognition Therapeutics
Cogstate
HVMN
Biogen Idec
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cognition-Enhancing Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cognition-Enhancing Drugs, with price, sales, revenue and global market share of Cognition-Enhancing Drugs from 2019 to 2022.
Chapter 3, the Cognition-Enhancing Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cognition-Enhancing Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Cognition-Enhancing Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cognition-Enhancing Drugs.
Chapter 13, 14, and 15, to describe Cognition-Enhancing Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Cognition-Enhancing Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cognition-Enhancing Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Oral
1.2.3 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Cognition-Enhancing Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Pharmacies
1.4 Global Cognition-Enhancing Drugs Market Size & Forecast
1.4.1 Global Cognition-Enhancing Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Cognition-Enhancing Drugs Sales in Volume (2017-2028)
1.4.3 Global Cognition-Enhancing Drugs Price (2017-2028)
1.5 Global Cognition-Enhancing Drugs Production Capacity Analysis
1.5.1 Global Cognition-Enhancing Drugs Total Production Capacity (2017-2028)
1.5.2 Global Cognition-Enhancing Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cognition-Enhancing Drugs Market Drivers
1.6.2 Cognition-Enhancing Drugs Market Restraints
1.6.3 Cognition-Enhancing Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Accelerated Intelligence
2.1.1 Accelerated Intelligence Details
2.1.2 Accelerated Intelligence Major Business
2.1.3 Accelerated Intelligence Cognition-Enhancing Drugs Product and Services
2.1.4 Accelerated Intelligence Cognition-Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Cognition Therapeutics
2.2.1 Cognition Therapeutics Details
2.2.2 Cognition Therapeutics Major Business
2.2.3 Cognition Therapeutics Cognition-Enhancing Drugs Product and Services
2.2.4 Cognition Therapeutics Cognition-Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Cogstate
2.3.1 Cogstate Details
2.3.2 Cogstate Major Business
2.3.3 Cogstate Cognition-Enhancing Drugs Product and Services
2.3.4 Cogstate Cognition-Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 HVMN
2.4.1 HVMN Details
2.4.2 HVMN Major Business
2.4.3 HVMN Cognition-Enhancing Drugs Product and Services
2.4.4 HVMN Cognition-Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Biogen Idec
2.5.1 Biogen Idec Details
2.5.2 Biogen Idec Major Business
2.5.3 Biogen Idec Cognition-Enhancing Drugs Product and Services
2.5.4 Biogen Idec Cognition-Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Cognition-Enhancing Drugs Breakdown Data by Manufacturer
3.1 Global Cognition-Enhancing Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Cognition-Enhancing Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Cognition-Enhancing Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Cognition-Enhancing Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Cognition-Enhancing Drugs Manufacturer Market Share in 2021
3.5 Global Cognition-Enhancing Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Cognition-Enhancing Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cognition-Enhancing Drugs Market Size by Region
4.1.1 Global Cognition-Enhancing Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Cognition-Enhancing Drugs Revenue by Region (2017-2028)
4.2 North America Cognition-Enhancing Drugs Revenue (2017-2028)
4.3 Europe Cognition-Enhancing Drugs Revenue (2017-2028)
4.4 Asia-Pacific Cognition-Enhancing Drugs Revenue (2017-2028)
4.5 South America Cognition-Enhancing Drugs Revenue (2017-2028)
4.6 Middle East and Africa Cognition-Enhancing Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Cognition-Enhancing Drugs Sales in Volume by Type (2017-2028)
5.2 Global Cognition-Enhancing Drugs Revenue by Type (2017-2028)
5.3 Global Cognition-Enhancing Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Cognition-Enhancing Drugs Sales in Volume by Application (2017-2028)
6.2 Global Cognition-Enhancing Drugs Revenue by Application (2017-2028)
6.3 Global Cognition-Enhancing Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Cognition-Enhancing Drugs Sales by Type (2017-2028)
7.2 North America Cognition-Enhancing Drugs Sales by Application (2017-2028)
7.3 North America Cognition-Enhancing Drugs Market Size by Country
7.3.1 North America Cognition-Enhancing Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Cognition-Enhancing Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Cognition-Enhancing Drugs Sales by Type (2017-2028)
8.2 Europe Cognition-Enhancing Drugs Sales by Application (2017-2028)
8.3 Europe Cognition-Enhancing Drugs Market Size by Country
8.3.1 Europe Cognition-Enhancing Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Cognition-Enhancing Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Cognition-Enhancing Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Cognition-Enhancing Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Cognition-Enhancing Drugs Market Size by Region
9.3.1 Asia-Pacific Cognition-Enhancing Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Cognition-Enhancing Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Cognition-Enhancing Drugs Sales by Type (2017-2028)
10.2 South America Cognition-Enhancing Drugs Sales by Application (2017-2028)
10.3 South America Cognition-Enhancing Drugs Market Size by Country
10.3.1 South America Cognition-Enhancing Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Cognition-Enhancing Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cognition-Enhancing Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Cognition-Enhancing Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Cognition-Enhancing Drugs Market Size by Country
11.3.1 Middle East & Africa Cognition-Enhancing Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Cognition-Enhancing Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Cognition-Enhancing Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Cognition-Enhancing Drugs
12.3 Cognition-Enhancing Drugs Production Process
12.4 Cognition-Enhancing Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Cognition-Enhancing Drugs Typical Distributors
13.3 Cognition-Enhancing Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Cognition-Enhancing Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Cognition-Enhancing Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Accelerated Intelligence Basic Information, Manufacturing Base and Competitors
Table 4. Accelerated Intelligence Major Business
Table 5. Accelerated Intelligence Cognition-Enhancing Drugs Product and Services
Table 6. Accelerated Intelligence Cognition-Enhancing Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Cognition Therapeutics Basic Information, Manufacturing Base and Competitors
Table 8. Cognition Therapeutics Major Business
Table 9. Cognition Therapeutics Cognition-Enhancing Drugs Product and Services
Table 10. Cognition Therapeutics Cognition-Enhancing Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Cogstate Basic Information, Manufacturing Base and Competitors
Table 12. Cogstate Major Business
Table 13. Cogstate Cognition-Enhancing Drugs Product and Services
Table 14. Cogstate Cognition-Enhancing Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. HVMN Basic Information, Manufacturing Base and Competitors
Table 16. HVMN Major Business
Table 17. HVMN Cognition-Enhancing Drugs Product and Services
Table 18. HVMN Cognition-Enhancing Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Biogen Idec Basic Information, Manufacturing Base and Competitors
Table 20. Biogen Idec Major Business
Table 21. Biogen Idec Cognition-Enhancing Drugs Product and Services
Table 22. Biogen Idec Cognition-Enhancing Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global Cognition-Enhancing Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
Table 24. Global Cognition-Enhancing Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in Cognition-Enhancing Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global Cognition-Enhancing Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 27. Head Office and Cognition-Enhancing Drugs Production Site of Key Manufacturer
Table 28. Cognition-Enhancing Drugs New Entrant and Capacity Expansion Plans
Table 29. Cognition-Enhancing Drugs Mergers & Acquisitions in the Past Five Years
Table 30. Global Cognition-Enhancing Drugs Sales by Region (2017-2022) & (K MT)
Table 31. Global Cognition-Enhancing Drugs Sales by Region (2023-2028) & (K MT)
Table 32. Global Cognition-Enhancing Drugs Revenue by Region (2017-2022) & (USD Million)
Table 33. Global Cognition-Enhancing Drugs Revenue by Region (2023-2028) & (USD Million)
Table 34. Global Cognition-Enhancing Drugs Sales by Type (2017-2022) & (K MT)
Table 35. Global Cognition-Enhancing Drugs Sales by Type (2023-2028) & (K MT)
Table 36. Global Cognition-Enhancing Drugs Revenue by Type (2017-2022) & (USD Million)
Table 37. Global Cognition-Enhancing Drugs Revenue by Type (2023-2028) & (USD Million)
Table 38. Global Cognition-Enhancing Drugs Price by Type (2017-2022) & (USD/MT)
Table 39. Global Cognition-Enhancing Drugs Price by Type (2023-2028) & (USD/MT)
Table 40. Global Cognition-Enhancing Drugs Sales by Application (2017-2022) & (K MT)
Table 41. Global Cognition-Enhancing Drugs Sales by Application (2023-2028) & (K MT)
Table 42. Global Cognition-Enhancing Drugs Revenue by Application (2017-2022) & (USD Million)
Table 43. Global Cognition-Enhancing Drugs Revenue by Application (2023-2028) & (USD Million)
Table 44. Global Cognition-Enhancing Drugs Price by Application (2017-2022) & (USD/MT)
Table 45. Global Cognition-Enhancing Drugs Price by Application (2023-2028) & (USD/MT)
Table 46. North America Cognition-Enhancing Drugs Sales by Country (2017-2022) & (K MT)
Table 47. North America Cognition-Enhancing Drugs Sales by Country (2023-2028) & (K MT)
Table 48. North America Cognition-Enhancing Drugs Revenue by Country (2017-2022) & (USD Million)
Table 49. North America Cognition-Enhancing Drugs Revenue by Country (2023-2028) & (USD Million)
Table 50. North America Cognition-Enhancing Drugs Sales by Type (2017-2022) & (K MT)
Table 51. North America Cognition-Enhancing Drugs Sales by Type (2023-2028) & (K MT)
Table 52. North America Cognition-Enhancing Drugs Sales by Application (2017-2022) & (K MT)
Table 53. North America Cognition-Enhancing Drugs Sales by Application (2023-2028) & (K MT)
Table 54. Europe Cognition-Enhancing Drugs Sales by Country (2017-2022) & (K MT)
Table 55. Europe Cognition-Enhancing Drugs Sales by Country (2023-2028) & (K MT)
Table 56. Europe Cognition-Enhancing Drugs Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe Cognition-Enhancing Drugs Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe Cognition-Enhancing Drugs Sales by Type (2017-2022) & (K MT)
Table 59. Europe Cognition-Enhancing Drugs Sales by Type (2023-2028) & (K MT)
Table 60. Europe Cognition-Enhancing Drugs Sales by Application (2017-2022) & (K MT)
Table 61. Europe Cognition-Enhancing Drugs Sales by Application (2023-2028) & (K MT)
Table 62. Asia-Pacific Cognition-Enhancing Drugs Sales by Region (2017-2022) & (K MT)
Table 63. Asia-Pacific Cognition-Enhancing Drugs Sales by Region (2023-2028) & (K MT)
Table 64. Asia-Pacific Cognition-Enhancing Drugs Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific Cognition-Enhancing Drugs Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific Cognition-Enhancing Drugs Sales by Type (2017-2022) & (K MT)
Table 67. Asia-Pacific Cognition-Enhancing Drugs Sales by Type (2023-2028) & (K MT)
Table 68. Asia-Pacific Cognition-Enhancing Drugs Sales by Application (2017-2022) & (K MT)
Table 69. Asia-Pacific Cognition-Enhancing Drugs Sales by Application (2023-2028) & (K MT)
Table 70. South America Cognition-Enhancing Drugs Sales by Country (2017-2022) & (K MT)
Table 71. South America Cognition-Enhancing Drugs Sales by Country (2023-2028) & (K MT)
Table 72. South America Cognition-Enhancing Drugs Revenue by Country (2017-2022) & (USD Million)
Table 73. South America Cognition-Enhancing Drugs Revenue by Country (2023-2028) & (USD Million)
Table 74. South America Cognition-Enhancing Drugs Sales by Type (2017-2022) & (K MT)
Table 75. South America Cognition-Enhancing Drugs Sales by Type (2023-2028) & (K MT)
Table 76. South America Cognition-Enhancing Drugs Sales by Application (2017-2022) & (K MT)
Table 77. South America Cognition-Enhancing Drugs Sales by Application (2023-2028) & (K MT)
Table 78. Middle East & Africa Cognition-Enhancing Drugs Sales by Region (2017-2022) & (K MT)
Table 79. Middle East & Africa Cognition-Enhancing Drugs Sales by Region (2023-2028) & (K MT)
Table 80. Middle East & Africa Cognition-Enhancing Drugs Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa Cognition-Enhancing Drugs Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa Cognition-Enhancing Drugs Sales by Type (2017-2022) & (K MT)
Table 83. Middle East & Africa Cognition-Enhancing Drugs Sales by Type (2023-2028) & (K MT)
Table 84. Middle East & Africa Cognition-Enhancing Drugs Sales by Application (2017-2022) & (K MT)
Table 85. Middle East & Africa Cognition-Enhancing Drugs Sales by Application (2023-2028) & (K MT)
Table 86. Cognition-Enhancing Drugs Raw Material
Table 87. Key Manufacturers of Cognition-Enhancing Drugs Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Cognition-Enhancing Drugs Typical Distributors
Table 91. Cognition-Enhancing Drugs Typical Customers
List of Figures
Figure 1. Cognition-Enhancing Drugs Picture
Figure 2. Global Cognition-Enhancing Drugs Revenue Market Share by Type in 2021
Figure 3. Oral
Figure 4. Injection
Figure 5. Global Cognition-Enhancing Drugs Revenue Market Share by Application in 2021
Figure 6. Hospital Pharmacies
Figure 7. Drug Stores
Figure 8. Retail Pharmacies
Figure 9. Global Cognition-Enhancing Drugs Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
Figure 10. Global Cognition-Enhancing Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Cognition-Enhancing Drugs Sales (2017-2028) & (K MT)
Figure 12. Global Cognition-Enhancing Drugs Price (2017-2028) & (USD/MT)
Figure 13. Global Cognition-Enhancing Drugs Production Capacity (2017-2028) & (K MT)
Figure 14. Global Cognition-Enhancing Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Cognition-Enhancing Drugs Market Drivers
Figure 16. Cognition-Enhancing Drugs Market Restraints
Figure 17. Cognition-Enhancing Drugs Market Trends
Figure 18. Global Cognition-Enhancing Drugs Sales Market Share by Manufacturer in 2021
Figure 19. Global Cognition-Enhancing Drugs Revenue Market Share by Manufacturer in 2021
Figure 20. Cognition-Enhancing Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Cognition-Enhancing Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Cognition-Enhancing Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Cognition-Enhancing Drugs Sales Market Share by Region (2017-2028)
Figure 24. Global Cognition-Enhancing Drugs Revenue Market Share by Region (2017-2028)
Figure 25. North America Cognition-Enhancing Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Europe Cognition-Enhancing Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Cognition-Enhancing Drugs Revenue (2017-2028) & (USD Million)
Figure 28. South America Cognition-Enhancing Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Cognition-Enhancing Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Global Cognition-Enhancing Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Cognition-Enhancing Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Cognition-Enhancing Drugs Price by Type (2017-2028) & (USD/MT)
Figure 33. Global Cognition-Enhancing Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Cognition-Enhancing Drugs Revenue Market Share by Application (2017-2028)
Figure 35. Global Cognition-Enhancing Drugs Price by Application (2017-2028) & (USD/MT)
Figure 36. North America Cognition-Enhancing Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Cognition-Enhancing Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Cognition-Enhancing Drugs Sales Market Share by Country (2017-2028)
Figure 39. North America Cognition-Enhancing Drugs Revenue Market Share by Country (2017-2028)
Figure 40. United States Cognition-Enhancing Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Cognition-Enhancing Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Cognition-Enhancing Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Cognition-Enhancing Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Cognition-Enhancing Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Cognition-Enhancing Drugs Sales Market Share by Country (2017-2028)
Figure 46. Europe Cognition-Enhancing Drugs Revenue Market Share by Country (2017-2028)
Figure 47. Germany Cognition-Enhancing Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Cognition-Enhancing Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Cognition-Enhancing Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Cognition-Enhancing Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Cognition-Enhancing Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Cognition-Enhancing Drugs Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Cognition-Enhancing Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Cognition-Enhancing Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Cognition-Enhancing Drugs Revenue Market Share by Region (2017-2028)
Figure 56. China Cognition-Enhancing Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Cognition-Enhancing Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Cognition-Enhancing Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Cognition-Enhancing Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Cognition-Enhancing Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Cognition-Enhancing Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Cognition-Enhancing Drugs Sales Market Share by Type (2017-2028)
Figure 63. South America Cognition-Enhancing Drugs Sales Market Share by Application (2017-2028)
Figure 64. South America Cognition-Enhancing Drugs Sales Market Share by Country (2017-2028)
Figure 65. South America Cognition-Enhancing Drugs Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Cognition-Enhancing Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Cognition-Enhancing Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Cognition-Enhancing Drugs Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Cognition-Enhancing Drugs Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Cognition-Enhancing Drugs Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Cognition-Enhancing Drugs Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Cognition-Enhancing Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Cognition-Enhancing Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Cognition-Enhancing Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Cognition-Enhancing Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Cognition-Enhancing Drugs in 2021
Figure 77. Manufacturing Process Analysis of Cognition-Enhancing Drugs
Figure 78. Cognition-Enhancing Drugs Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 認知機能増進薬のグローバル市場展望 2023年-2029年：経口型、注射型
  • トレッドグリップ強化樹脂のグローバル市場展望 2023年-2029年：エポキシ樹脂、ビニル樹脂、フェノール樹脂
  • 世界のオシメルチニブ医薬品市場2022年：市場規模予測（～2028年）
  • 世界のエクセナチド薬物市場2022年：市場規模予測（～2028年）
  • 世界のペガスパルガーゼ薬物市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19239 )"世界の認知増強医薬品市場2022年：市場規模予測（～2028年）" (英文：Global Cognition-Enhancing Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。